Gilead Sciences, Inc.

Form 483 issued December 9, 2011 · Foster City, California

Inspection
Dec 5 – Dec 9, 2011
Observations
2
Pages
1
FEI number
1000523075

In short: On December 9, 2011, FDA issued a Form 483 with 2 observations to Gilead Sciences, Inc. in Foster City, California (FEI 1000523075) after an inspection that ran Dec 5 – Dec 9, 2011. The investigators were Arindam Dasgupta and Kevin P. Foley. Most observations concern gLP; the most-cited regulation is 21 CFR 58.130 (conduct of a nonclinical laboratory study).

At a glance

2 of 2 observations on this 483 concern glp.

GLP2

Most cited: 21 CFR 58.190 (1×) · 58.130 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to conduct a re-injection reprodt eriment during pre-study method validation for (MAMMPmethod. Samples for subject…

  2. 02

    Failure to document all…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Gilead Sciences, Inc.?

FDA listed 2 observations on this Form 483, mostly about gLP. The most-cited regulation is 21 CFR 58.130 (conduct of a nonclinical laboratory study). The opening words of each observation are shown on this page.

Who inspected Gilead Sciences, Inc.?

Arindam Dasgupta and Kevin P. Foley are named on this Form 483, for the inspection of Dec 5 – Dec 9, 2011. Each investigator has a profile showing what they cite most.

When was Gilead Sciences, Inc. inspected by FDA?

The inspection ran Dec 5 – Dec 9, 2011, and the Form 483 is dated December 9, 2011.

How do I get the full Form 483 for Gilead Sciences, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free